Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation

Liver Transplantation

Volumn 21, Issue 5, 2015, Pages 599-606

  Chaiteerakij, Roongruedee ^a,e,f   Zhang, Xiaodan ^a   Addissie, Benyam D ^a   Mohamed, Essa A ^a   Harmsen, William S ^b   Theobald, Paul J ^c   Peters, Brian E ^c   Balsanek, Joseph G ^c   Ward, Melissa M ^c   Giama, Nasra H ^a   Moser, Catherine D ^a   Oseini, Abdul M ^a   Umeda, Naoki ^a   Venkatesh, Sudhakar ^d   Harnois, Denise M ^b   Charlton, Michael R ^a   Yamada, Hiroyuki ^g   Satomura, Shinji ^g   Algeciras Schimnich, Alicia ^c   Snyder, Melissa R ^c   Therneau, Terry M ^b   Roberts, Lewis R ^a   more..

^a MAYO CLINIC CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

^d Mayo Clinic College of Medicine   (United States)

^e CHULALONGKORN UNIVERSITY   (Thailand)

^f KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^g Wako Life Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ REACTIVE ALPHA FETOPROTEIN; ALBUMIN; ALPHA FETOPROTEIN; BILIRUBIN; CREATININE; DECARBOXYPROTHROMBIN; TUMOR MARKER; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; LENTIL LECTIN; PLANT LECTIN; PROTEIN PRECURSOR; PROTHROMBIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER RECURRENCE; CANCER SIZE; CANCER TRANSPLANTATION; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSESSMENT; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; INTERNATIONAL NORMALIZED RATIO; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MILAN CRITERIA; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; AGED; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TUMOR RECURRENCE; X-RAY COMPUTED TOMOGRAPHY;

AGED; ALPHA-FETOPROTEINS; BIOMARKERS; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PLANT LECTINS; PROPORTIONAL HAZARDS MODELS; PROTEIN PRECURSORS; PROTHROMBIN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84928570317     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24117     Document Type: Article

References (18)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-E386.
2. Bruix J, Sherman M,; for American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
3. Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt JR, Cameron AM, Hong J, Busuttil RW,. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg 2008; 143: 182-188.
4. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
5. Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A,; for OLT for HCC Consensus Group. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 2012; 13: e11-e22.
6. Hakeem AR, Young RS, Marangoni G, Lodge JP, Prasad KR,. Systematic review: the prognostic role of alpha-fetoprotein following liver transplant for hepatocellular carcinoma. Aliment Pharmacol Ther 2012; 35: 987-999.
7. Dumitra TC, Dumitra S, Metrakos PP, Barkun JS, Chaudhury P, Deschênes M, et al. Pretransplantation alpha-fetoprotein slope and Milan criteria: strong predictors of hepatocellular carcinoma recurrence after transplantation. Transplantation 2013; 95: 228-233.
8. Fujiki M, Takada Y, Ogura Y, Oike F, Kaido T, Teramukai S, Uemoto S,. Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma. Am J Transplant 2009; 9: 2362-2371.
9. Shindoh J, Sugawara Y, Nagata R, Kaneko J, Tamura S, Aoki T, et al. Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma. Transpl Int 2014; 27: 391-398.
10. Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T, et al.; for Liver Transplantation French Study Group. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology 2012; 143: 986-994.
11. Chaiteerakij R, Addissie BD, Roberts LR,. Update on biomarkers of hepatocellular carcinoma. Clin Gastroenterol Hepatol 2015; 13: 237-245.
12. Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T, et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 2009; 87: 531-537.
13. Shirabe K, Itoh S, Yoshizumi T, Soejima Y, Taketomi A, Aishima S, Maehara Y,. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 2007; 95: 235-240.
14. Lencioni R, Llovet JM,. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30: 52-60.
15. Kim DJ, Clark PJ, Heimbach J, Rosen C, Sanchez W, Watt K, Charlton MR,. Recurrence of hepatocellular carcinoma: importance of mRECIST response to chemoembolization and tumor size. Am J Transplant 2014; 14: 1383-1390.
16. Fujikawa T, Shiraha H, Ueda N, Takaoka N, Nakanishi Y, Matsuo N, et al. Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration. J Biol Chem 2007; 282: 8741-8748.
17. Carr BI, Kanke F, Wise M, Satomura S,. Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States. Dig Dis Sci 2007; 52: 776-782.
18. Zheng Z, Liang W, Milgrom DP, Zheng Z, Schroder PM, Kong NS, et al. Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies. Transplantation 2014; 97: 227-234.